Australia Clears Kimberly Clark Kenvue Deal

Australia antitrust regulators approved Kimberly Clark's acquisition of Kenvue under the condition that the company divests its Carefree and Stayfree brands locally. The measure aims to preserve competition in the domestic period care market.

Xurve View
Insights:
The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. REUTERS/Brendan McDermid

Australia cleared KIMBERLY-CLARK CORP's $40 billion acquisition of KENVUE INC on Wednesday morning. The approval requires the divestment of specific hygiene brands to preserve domestic market competition. The deal gives Kimberly-Clark control of global brands including Listerine and Neutrogena.

IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.